Related Experiment Videos
Increasing choices for HIV therapy
1Columbia Presbyterian Medical Center, New York, NY 10032, USA.
The New England Journal of Medicine
|June 28, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies.
EBioMedicine·2020
Same author
Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State Area.
Transgender health·2020
Same author
Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.
The Journal of clinical investigation·2019
Same author
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
Journal of virology·2019
Same author
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.
The Journal of infectious diseases·2018
Same author
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
PloS one·2017
Same journal
Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609.
The New England journal of medicine·2026
Same journal
Opportunities to Combat the Chronic Pain-Opioid Use Disorder Syndemic.
The New England journal of medicine·2026
Same journal
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.
The New England journal of medicine·2026
Same journal
Declarations of Independence - Physicians and the U.S. Body Politic, 1776-2026.
The New England journal of medicine·2026